Filing Details
- Accession Number:
- 0000899243-21-017113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 17:05:45
- Reporting Period:
- 2021-04-23
- Accepted Time:
- 2021-04-27 17:05:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724979 | Rain Therapeutics Inc. | RAIN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1273885 | M Franklin Berger | C/O Rain Therapeutics Inc. 8000 Jarvis Avenue, Suite 204 Newark CA 94560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-23 | 120,000 | $17.00 | 120,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-23 | 5,000 | $15.78 | 125,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-04-27 | 175,939 | $0.00 | 300,939 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-04-27 | 535,601 | $0.00 | 836,540 | No | 4 | C | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2021-04-27 | 189,998 | $0.00 | 175,939 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2021-04-27 | 578,397 | $0.00 | 535,601 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- The Series B Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date.
Billionaire Hedge Funds
